In the previous four articles in this series (see here) we looked at the key role of professional investors at startups, though also at the setbacks of the exclusive dependence of these types of companies on equity and the advantages debt would have for them. The environment, as we saw, is also a favorable one for borrowing. We described the difficulty to provide general recipes for getting debt and a few not very promising routes.

En los cuatro artículos anteriores de esta serie (ver aquí) analizamos el papel clave de los inversores profesionales en las 'startups', pero también las desventajas de la exclusiva dependencia de este tipo de empresas del 'equity' y las ventajas que tendría la deuda para ellas. El entorno, como vimos, es además favorable para el endeudamiento. Abordamos la dificultad de ofrecer recetas generales para conseguir deuda y algunas vías no muy prometedoras.

Over the summer, we wrote about why health care companies may want to consider buying assets out of bankruptcy, taking advantage of the Bankruptcy Code Section 363 sale process (a “363 Sale”). We are back with our second post, to provide more detail to the process and discuss some pros and cons of 363 Sales.

This two-part blog series discusses why buyers looking to make strategic purchases in the health care industry might want to take advantage of the Bankruptcy Code Section 363 sale process (363 Sale) and the pros and cons of buying assets out of bankruptcy through a 363 Sale.